Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy
Masoud Delfi, Rossella Sartorius, Milad Ashrafizadeh, et al.
Nano Today (2021) Vol. 38, pp. 101119-101119
Open Access | Times Cited: 193
New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111824-111824
Open Access | Times Cited: 152
NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 141
Molecular mechanisms of platinum‑based chemotherapy resistance in ovarian cancer (Review)
Ling Yang, Hongjian Xie, Yingying Li, et al.
Oncology Reports (2022) Vol. 47, Iss. 4
Open Access | Times Cited: 139
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 133
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 108
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis
Afshin Taheriazam, Ghazaleh Gholamiyan Yousef Abad, Shima Hajimazdarany, et al.
Journal of Controlled Release (2023) Vol. 354, pp. 503-522
Open Access | Times Cited: 49
Understanding exosomes: Part 2—Emerging leaders in regenerative medicine
Richard J. Miron, Nathan E. Estrin, Anton Sculean, et al.
Periodontology 2000 (2024) Vol. 94, Iss. 1, pp. 257-414
Open Access | Times Cited: 15
Targeting of cancer cell death mechanisms by resveratrol: a review
Xiao Fu, Mu Li, Cuilian Tang, et al.
APOPTOSIS (2021) Vol. 26, Iss. 11-12, pp. 561-573
Closed Access | Times Cited: 68
Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications
Milad Ashrafizadeh, Alan Prem Kumar, Amir Reza Aref, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1229-1253
Open Access | Times Cited: 58
Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy
Yu Chong, Bo Yang, Masoud Najafi
Basic & Clinical Pharmacology & Toxicology (2021) Vol. 129, Iss. 6, pp. 397-415
Open Access | Times Cited: 54
The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review
Bahareh Farasati Far, Kimia Vakili, Mobina Fathi, et al.
Life Sciences (2022) Vol. 316, pp. 121340-121340
Closed Access | Times Cited: 54
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions
Maliheh Entezari, Afshin Taheriazam, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113609-113609
Open Access | Times Cited: 52
The interplay between oxidative stress and autophagy: focus on the development of neurological diseases
Marjan Talebi, Seyyed Ali Mohammadi Vadoud, Alireza Haratian, et al.
Behavioral and Brain Functions (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 40
Non-coding RNAs and macrophage interaction in tumor progression
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
Dan Liu, Hongtao Zhu, Chuanzhou Li
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 24
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research (2023) Vol. 233, pp. 116458-116458
Closed Access | Times Cited: 21
Autophagy in cancer immunotherapy: Perspective on immune evasion and cell death interactions
Qiang Yu, Jiajun Ding, Shisen Li, et al.
Cancer Letters (2024) Vol. 590, pp. 216856-216856
Closed Access | Times Cited: 8
Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Courtney Clark, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1868, Iss. 3, pp. 166326-166326
Open Access | Times Cited: 53
Gene regulation by antisense transcription: A focus on neurological and cancer diseases
Sajad Najafi, Shing Cheng Tan, Pourya Raee, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112265-112265
Open Access | Times Cited: 42
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
Sepideh Mirzaei, Mohammad Gholami, Hui Li Ang, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3348-3348
Open Access | Times Cited: 42
Sulforaphane inhibits NLRP3 inflammasome activation in microglia through Nrf2-mediated miRNA alteration
Kemal Uğur Tüfekçi, İlkcan Ercan, Kamer Burak Isci, et al.
Immunology Letters (2021) Vol. 233, pp. 20-30
Open Access | Times Cited: 40
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 34
Epigenetic regulation of autophagy in gastrointestinal cancers
Saeid Ghavami, Mozhdeh Zamani, Mazaher Ahmadi, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 11, pp. 166512-166512
Open Access | Times Cited: 29
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top